Gene Technology

Advancements and Implications of Genetically Modified Organisms in Modern Gene Technology

Mohsen Khormi^* Department of Biology, Jazan University, Jazan, Saudi Arabia
^*Correspondence: Mohsen Khormi, Department of Biology, Jazan University, Jazan, Saudi Arabia, Email:

Received: 01-Mar-2025, Manuscript No. RDT-25-29027; Editor assigned: 03-Mar-2025, Pre QC No. RDT-25-29027 (PQ); Reviewed: 17-Mar-2025, QC No. RDT-25-29027; Revised: 24-Mar-2025, Manuscript No. RDT-25-29027 (R); Published: 31-Mar-2025, DOI: 10.35248/2329-6682.25.14.309

References

1. Dokmai N, Kockan C, Zhu K, Wang X, Sahinalp SC, Cho H. Privacy-preserving genotype imputation in a trusted execution environment. Cell Syst. 2021;12(10):983-993.

   [Crossref] [Google Scholar] [PubMed]

2. Bonomi L, Huang Y, Ohno-Machado L. Privacy challenges and research opportunities for genomic data sharing. Nat Genet. 2020;52(7):646-654.

   [Crossref] [Google Scholar] [PubMed]

3. Sankararaman S, Obozinski G, Jordan MI, Halperin E. Genomic privacy and limits of individual detection in a pool.  Nat Genet. 2009;41(9):965-967.

   [Crossref] [Google Scholar] [PubMed]

4. Homer N, Szelinger S, Redman M, Duggan D, Tembe W, Muehling J, et al. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density snp genotyping microarrays. PLoS Genet. 2008; 4(8):e1000167.

   [Crossref] [Google Scholar] [PubMed]

5. Dinur I, Nissim K. Revealing information while preserving privacy. In Proceedings of the twenty-second ACM SIGMOD-SIGACT-SIGART symposium on Principles of database systems. 2003:202-210.

   [Crossref] [Google Scholar]

6. Erlich Y, Shor T, Pe’er I, Carmi S. Identity inference of genomic data using long-range familial searches.  Science. 2018:362;690-694.

   [Crossref] [Google Scholar] [PubMed]

7. Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y. Identifying personal genomes by surname inference. Science. 2013;339(6117):321-324. 

   [Crossref] [Google Scholar] [PubMed]

8. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet. 2012 Jan 13;90(1):7-24.

   [Crossref] [Google Scholar] [PubMed]

9. Korte A, Farlow A. The advantages and limitations of trait analysis with GWAS: A review. Plant methods. 2013;9(1):1-9.

   [Crossref] [Google Scholar] [PubMed]

10. Visscher PM, Wray NR, Zhang Q, Sklar P, McCarthy MI, Brown MA, et al. 10 years of GWAS discovery: biology, function, and translation. Am J Hum Genet. 2017;101(1):5-22.

    [Crossref] [Google Scholar] [PubMed]

Description

Genetically Modified Organisms (GMOs) represent one of the most transformative achievements in modern gene technology. By altering the genetic material of an organism through recombinant DNA technology, scientists have enabled organisms to exhibit traits that are not naturally found in their species. These traits may include resistance to pests, tolerance to herbicides, improved nutritional content, or production of therapeutic proteins. GMOs have broad applications in agriculture, medicine, and industrial biotechnology, and their development continues to raise scientific, ethical, and ecological considerations [1–3].

In agriculture, GMOs have significantly increased crop productivity and sustainability. Crops such as Bt cotton, golden rice, and herbicide-resistant soybeans are widely cultivated in several parts of the world. Bt cotton expresses a gene from Bacillus thuringiensis, enabling it to produce a protein toxic to specific insect pests. This reduces the need for chemical pesticides, benefiting both the environment and human health. Golden rice, engineered to produce beta-carotene, aims to address vitamin A deficiency in regions where rice is a staple food. These innovations underscore how gene technology can directly address global food security and malnutrition challenges [4].

Beyond agriculture, GMOs have found essential applications in the pharmaceutical industry. Genetically engineered bacteria and mammalian cells are commonly used to produce insulin, growth hormones, vaccines, and monoclonal antibodies. The production of recombinant human insulin by genetically modified Escherichia coli revolutionized diabetes treatment by offering a more consistent and allergy-free source of insulin. Similarly, genetically engineered yeast and Chinese Hamster Ovary (CHO) cells have become standard platforms for producing complex therapeutic proteins, exemplifying the utility of GMOs in biopharmaceutical development [5].

In environmental biotechnology, GMOs are being explored for their potential in bioremediation. Genetically engineered microbes capable of degrading environmental pollutants such as oil spills, heavy metals, and plastics are under investigation. These microbes can be designed to metabolize toxic compounds into less harmful forms, contributing to ecological restoration. Moreover, synthetic biology is enabling the design of novel biosensors using GMOs, which can detect environmental toxins or pathogens with high sensitivity [6].

Despite their advantages, GMOs remain a subject of intense public and scientific debate. Concerns often center on biosafety, ecological balance, and food labeling transparency. The potential for gene flow from genetically modified crops to wild relatives, development of pest resistance, and unintended effects on non-target organisms must be carefully assessed [7]. Regulatory bodies such as the FDA, EFSA, and WHO have established rigorous protocols for evaluating the safety of GMOs before commercialization. Still, continuous monitoring and post-market surveillance are essential to maintain ecological integrity.

Advancements in gene-editing tools like CRISPR-Cas9 have further refined the development of GMOs by enabling precise, targeted modifications with minimal off-target effects. This technology opens new avenues for creating organisms with desirable traits while potentially avoiding the regulatory complexities associated with transgenic organisms [8-10]. CRISPR-based editing is now being applied not only in plants and animals but also in microorganisms used for biofuel production, enzyme synthesis, and synthetic materials.

In conclusion, genetically modified organisms are pivotal in shaping the future of gene technology. Their contributions to agriculture, medicine, and environmental management are undeniable. However, realizing their full potential requires a balanced approach that incorporates innovation, regulation, public trust, and ethical responsibility. As research progresses, GMOs will continue to be at the forefront of biotechnology, offering solutions to some of humanity’s most pressing challenges.